New osteoporosis drug put to safety test in indian women
NCT ID NCT06079476
Summary
This study tested the safety and side effects of a bone-building medication called romosozumab (EVENITY®) in 100 postmenopausal women in India who have osteoporosis and a high risk of breaking a bone. The main goal was to see how well the women tolerated the drug and to monitor for any health problems. Researchers also checked if the treatment improved bone density in the spine and hip.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Apollo Hospital
New Delhi, National Capital Territory of Delhi, 110076, India
-
Christain Medical College
Vellore, Tamil Nadu, 632004, India
-
King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College
Mumbai, Maharashtra, 400012, India
-
King Georges Medical University
Lucknow, Uttar Pradesh, 226 003, India
-
MGM Healthcare
Chennai, Tamil Nadu, 600 029, India
-
MS Ramaiah Medical College and Hospitals
Bangalore, Karnataka, 560054, India
-
Post Graduate Institute of Medical Education and Research
Chandigarh, Punjab, 160 012, India
-
Sancheti Institute for Orthopedics and rehabilitation
Pune, Maharashtra, 411005, India
-
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, 110060, India
-
Stavya Spine Hospital and Research Institute SSHRI
Ahmedabad, Gujarat, 380 007, India
Conditions
Explore the condition pages connected to this study.